Obama frees stem cell research from Bush-era ban
President Obama has finally done something good! On Monday, he signed an executive order rescinding the ban on federal funding of embryonic stem cell research. The order reverses a policy imposed by...
View ArticleClik here to view.
The Expanding FDA
A lawsuit between the FDA and a medical technology company, Regenerative Sciences, has been getting attention recently. The company has pioneered a procedure (Regenexx-C) whereby a person’s own stem...
View ArticleClik here to view.
Do Stem Cell Therapies Stand a Chance Against the FDA?
There is currently a debate underway about the FDA’s authority to regulate stem cell therapies. The FDA is suing a Colorado-based company, Regenerative Sciences, which has developed a procedure to...
View ArticleClik here to view.
FDA Versus Stem Cell Therapies
Who owns your cells? The FDA seems to think it does, given its lawsuit against Regenerative Sciences, a company that treats orthopedic injuries by extracting, culturing and reinjecting adult stem cells...
View ArticleClik here to view.
Daily Caller: Will FDA choke off promising adult stem cell research?
ARC fellow Keith Lockitch has an editorial published in The Daily Caller today about the recent U.S. District Court decision to grant the FDA control over stem cell therapies (we’ve written about this...
View ArticleClik here to view.
The FDA vs. Patients
Next Wednesday, October 9, I’ll be speaking on a panel at the National Press Club in Washington, D.C. The discussion is titled “The FDA versus Patients: Asking the Government for Permission to Live.”...
View Article
